Familial amyloidosis history and symptoms: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 2: Line 2:
{{Familial amyloidosis}}
{{Familial amyloidosis}}


{{CMG}}; {{AE}} {{F.K}}
{{CMG}}; {{AE}} {{Fs}}, {{F.K}}
==Overview==
==Overview==
Common [[symptoms]] of familial amyloidosis include [[abdominal pain]], [[edema]],[[enlarged tongue]], skin and nail changes. Less common [[symptoms]] of amyloidosis include [[Gastrointestinal bleeding|gastrointestinal bleeding, gross]] [[hematuria]], [[hoarseness]] and [[paresthesias]].  
Common [[symptoms]] of familial amyloidosis include [[abdominal pain]], [[edema]],[[enlarged tongue]], skin and nail changes. Less common [[symptoms]] of amyloidosis include [[Gastrointestinal bleeding|gastrointestinal bleeding, gross]] [[hematuria]], [[hoarseness]] and [[paresthesias]].  

Revision as of 16:28, 11 November 2019

Familial amyloidosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Familial amyloidosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Familial amyloidosis history and symptoms On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Familial amyloidosis history and symptoms

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Familial amyloidosis history and symptoms

CDC on Familial amyloidosis history and symptoms

Familial amyloidosis history and symptoms in the news

Blogs on Familial amyloidosis history and symptoms

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Familial amyloidosis history and symptoms

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D., Farima Kahe M.D. [2]

Overview

Common symptoms of familial amyloidosis include abdominal pain, edema,enlarged tongue, skin and nail changes. Less common symptoms of amyloidosis include gastrointestinal bleeding, gross hematuria, hoarseness and paresthesias.

History and Symptoms

Common symptoms of familial amyloidosis include abdominal pain, edema and enlarged tongue. Less common symptoms of amyloidosis include gastrointestinal bleeding, gross hematuria, hoarseness and paresthesias.

History

Patients with amyloidosis may have a positive history of:[1]

Common Symptoms

Common symptoms of ATTR familial amyloidosis include:

  • Parasthesia
  • Muscle weakness
  • Sexual problems
  • Constipation/ diarrhea
  • Urination problems
  • Weakness
  • Fatigue
  • Edema
  • Palpitation
  • Dizziness

Common symptoms of Apolipoprotein AI familial amyloidosis include:[2][3]

  • Parasthesia
  • Edema
  • Cutaneous lesions
  • Hoarseness
  • Cough

Common symptoms of Gesolin familial amyloidosis include:[4]

  • Vision problems
  • Droopy appearance of face, neck, and armpitt
  • A tingling sensation in face
  • Drooling or slurred speech

Common symptoms of Lysozyme familial amyloidosis include:[5][6]

Common symptoms of Cystatin C familial amyloidosis include:[7][8]

  • Balance problems
  • Headache
  • Increase head size
  • Seizures
  • Loss of intellectual function

Common symptoms of Fibrinogen Aa-chain familial amyloidosis include:[9]

  • Hypertension
  • Edema
  • Fatigue

Common symptoms of Apolipoprotein AII familial amyloidosis include:[10]

  • Edema
  • Fatigue

Less Common Symptoms

Less common symptoms of familial amyloidosis include:[11]

References

  1. Mahmood S, Palladini G, Sanchorawala V, Wechalekar A (February 2014). "Update on treatment of light chain amyloidosis". Haematologica. 99 (2): 209–21. doi:10.3324/haematol.2013.087619. PMC 3912950. PMID 24497558.
  2. Van Allen MW, Frohlich JA, Davis JR (January 1969). "Inherited predisposition to generalized amyloidosis. Clinical and pathological study of a family with neuropathy, nephropathy, and peptic ulcer". Neurology. 19 (1): 10–25. doi:10.1212/wnl.19.1.10. PMID 4304452.
  3. Hamidi Asl K, Liepnieks JJ, Nakamura M, Parker F, Benson MD (April 1999). "A novel apolipoprotein A-1 variant, Arg173Pro, associated with cardiac and cutaneous amyloidosis". Biochem. Biophys. Res. Commun. 257 (2): 584–8. doi:10.1006/bbrc.1999.0518. PMID 10198255.
  4. Meretoja J (December 1969). "Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes and various internal symptoms. A previously unrecognized heritable syndrome". Ann. Clin. Res. 1 (4): 314–24. PMID 4313418.
  5. Lim AY, Lee JH, Jung KS, Gwag HB, Kim DH, Kim SJ, Lee GY, Kim JS, Kim HJ, Lee SY, Lee JE, Jeon ES, Kim K (July 2015). "Clinical features and outcomes of systemic amyloidosis with gastrointestinal involvement: a single-center experience". Korean J. Intern. Med. 30 (4): 496–505. doi:10.3904/kjim.2015.30.4.496. PMC 4497337. PMID 26161016.
  6. Baker KR, Rice L (2012). "The amyloidoses: clinical features, diagnosis and treatment". Methodist Debakey Cardiovasc J. 8 (3): 3–7. PMC 3487569. PMID 23227278.
  7. Gudmundsson G, Hallgrímsson J, Jónasson TA, Bjarnason O (1972). "Hereditary cerebral haemorrhage with amyloidosis". Brain. 95 (2): 387–404. doi:10.1093/brain/95.2.387. PMID 4655034.
  8. Ghiso J, Pons-Estel B, Frangione B (April 1986). "Hereditary cerebral amyloid angiopathy: the amyloid fibrils contain a protein which is a variant of cystatin C, an inhibitor of lysosomal cysteine proteases". Biochem. Biophys. Res. Commun. 136 (2): 548–54. doi:10.1016/0006-291x(86)90475-4. PMID 3707586.
  9. Gillmore JD, Booth DR, Rela M, Heaton ND, Rahman V, Stangou AJ, Pepys MB, Hawkins PN (May 2000). "Curative hepatorenal transplantation in systemic amyloidosis caused by the Glu526Val fibrinogen alpha-chain variant in an English family". QJM. 93 (5): 269–75. doi:10.1093/qjmed/93.5.269. PMID 10825402.
  10. Weiss SW, Page DL (September 1973). "Amyloid nephropathy of Ostertag with special reference to renal glomerular giant cells". Am. J. Pathol. 72 (3): 447–60. PMC 1904021. PMID 4728894.
  11. Hamidi Asl K, Liepnieks JJ, Nakamura M, Benson MD (May 1999). "Organ-specific (localized) synthesis of Ig light chain amyloid". J. Immunol. 162 (9): 5556–60. PMID 10228037.

Template:WH Template:WS